Blackbaud Reaches New 52-Week High (BLKB)

NEW YORK ( TheStreet) -- Blackbaud (Nasdaq: BLKB) hit a new 52-week high Wednesday as it is currently trading at $31.08, above its previous 52-week high of $31.04 with 166,368 shares traded as of 11:54 a.m. ET. Average volume has been 172,100 shares over the past 30 days.

Blackbaud has a market cap of $1.33 billion and is part of the technology sector and computer software & services industry. Shares are up 9.9% year to date as of the close of trading on Tuesday.

Blackbaud, Inc. provides software and related services for nonprofit organizations worldwide. The company has a P/E ratio of 38.3, above the average computer software & services industry P/E ratio of 37.8 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Blackbaud as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, good cash flow from operations and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full Blackbaud Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing